scholarly journals Pulmonary Artery Thrombi Detected by Echocardiography in Patients with Pulmonary Hypertension Secondary to Atrial Septal Defect

2001 ◽  
Vol 2 (3) ◽  
pp. 149-153
Author(s):  
C Kaymaz
2020 ◽  
Vol 10 (2) ◽  
pp. 204589402091583 ◽  
Author(s):  
Reza S. Pratama ◽  
Anggoro B. Hartopo ◽  
Dyah W. Anggrahini ◽  
Vera C. Dewanto ◽  
Lucia K. Dinarti

Uncorrected atrial septal defect undergoes right ventricle chronic volume overload which may lead to pulmonary hypertension and Eisenmenger Syndrome. The soluble suppression of tumorigenicity-2 is a left ventricle strain biomarker; however, its role in right ventricle strain is unclear. This study aimed to investigate the implication of serum soluble suppression of tumorigenicity-2 in adult uncorrected atrial septal defect. This was a cross-sectional study. We enrolled 81 adult uncorrected secundum atrial septal defect patients. Clinical and hemodynamic data were collected. Serum samples were withdrawn from the pulmonary artery during right heart catheterization. Serum soluble suppression of tumorigenicity-2 and NT-proBNP levels were measured. Subjects were divided into three groups based on clinical and hemodynamic severity. The correlation of soluble suppression of tumorigenicity-2 with patients' data and comparison among groups were analyzed. A p value <0.05 was considered statistically significant. Results showed that, there were significant correlations between serum soluble suppression of tumorigenicity-2 and mean pulmonary artery pressure ( r = 0.203, p = 0.035) and right ventricle end-diastolic diameter ( r = 0.203, p <0.05). Median serum soluble suppression of tumorigenicity-2 level was incrementally increased from group I (atrial septal defect and no-pulmonary hypertension), group II (left-to-right atrial septal defect and pulmonary hypertension), to group III (Eisenmenger Syndrome): (17.4 ng/mL, 21.8 ng/mL, and 29.4 ng/mL, respectively). A post-hoc analysis showed that serum soluble suppression of tumorigenicity-2 level was significantly different between groups I and III ( p = 0.01). Serum N terminal pro brain natriuretic peptide (NT-proBNP) level was consistently associated with worse clinical and hemodynamic parameters. No correlation was found between serum soluble suppression of tumorigenicity-2 and NT-proBNP level. In conclusion, serum soluble suppression of tumorigenicity-2 level had significant positive correlation with mean pulmonary artery pressure and right ventricle end-diastolic diameter in uncorrected secundum atrial septal defect patients. Higher serum soluble suppression of tumorigenicity-2 level was associated with the presence of pulmonary hypertension and Eisenmenger Syndrome in uncorrected secundum atrial septal defect patients.


Cardiology ◽  
2002 ◽  
Vol 97 (1) ◽  
pp. 53-54 ◽  
Author(s):  
Nobukazu Ishizaka ◽  
Norihide Kage ◽  
Haruko Iida ◽  
Shinsuke Mutoh ◽  
Yasunobu Hirata ◽  
...  

2021 ◽  
pp. 1-3
Author(s):  
Saurabh Kumar Gupta ◽  
Sakshi Sachdeva ◽  
Rajnish Juneja

Abstract Pulmonary hypertension is not the only cause of arterial desaturation in patients with atrial septal defect. Arterial desaturation can also occur with normal pulmonary artery pressure making it mandatory to understand the mechanism to avoid erroneous diagnosis. In this report, for the first time, we demonstrate atrial flutter as the cause of arterial desaturation in a patient with large atrial septal defect despite normal pulmonary artery pressure, which was normalised following successful radiofrequency ablation.


2018 ◽  
Vol 3 (2) ◽  
pp. 106
Author(s):  
Jessica Wiryanto ◽  
Ingrid M. Pardede ◽  
Sunanto Ng

Pulmonary hypertension is a common complication of congenital heart disease due to systemic – pulmonary circulation shunt which if left uncorrected leads to increased pulmonary artery pressure, vascular remodeling and further increase of pulmonary vascular resistance. Percutaneous closure of the defect interrupts this shunt thus reducing right heart and pulmonary circulation load and pulmonary artery pressure. In this paper we present two cases of percutaneous secundum atrial septal defect closure complicated by pulmonary hypertension along with echocardiographic evaluation of cardiopulmonary hemodynamic changes before and shortly after device closure. Forty years old and thirty three years old females presented to our clinics with classical symptoms of atrial septal defects, assessment revealed TVG of 37 mmHg and 30 mmHg,shortly after the procedure patient was re-evaluated and revealed TVG of 39 mmHg and 23 mmHg respectively. From these cases we conclude that changes in pulmonary artery pressure is not constantly found after device closure. However both patients display improvements in functional capabilities.


2011 ◽  
Vol 7 (3) ◽  
pp. E6-E9 ◽  
Author(s):  
Utku Arman Orun ◽  
Osman Yilmaz ◽  
Meki Bilici ◽  
Selmin Karademir ◽  
Cigdem Uner ◽  
...  

Author(s):  
Jennifer Huang ◽  
Zach Hutchinson ◽  
Grant Burch ◽  
Brendan Kelly ◽  
Erin Madriago

Background: Pulmonary hypertension is a significant yet rare disease that can have many long-term consequences, including death. Cardiac catheterization is the gold standard for measuring pulmonary artery mean pressures (PAMP), but is invasive and risks potentially serious complications. This study aimed to create a semi-quantitative, non-invasive measure of PAMP using septal positioning. Methods: This study was a retrospective study of patients with and without pulmonary hypertension who had a transthoracic echocardiogram and cardiac catheterization. Patients undergoing atrial septal defect closure represented controls. Two blinded readers calculated the “Echocardiographically-Derived Septal Positional Angle (EDSPA)” which was compared to corresponding catheterization data including mean pulmonary artery pressures. Results: A total of 159 children were included, of which 151 had useable echocardiographic data. 40 children were identified as having pulmonary hypertension while 111 children had an atrial septal defect. Patient age ranged from a minimum of 54 days and maximum of 19 years [mean 7.1 years (SD=5.30)]. Inter-observer variability between two readers [Pearson correlation coefficient of 0.939 (p <0.001)] and intra-observer variability were low [intraclass correlation coefficient (ICC) of 0.95 and 0.96 for each observer respectively]. An EDSPA of ≤39° predicted a PAMP>20 mmHg (as measured by cardiac catheterization) with a 76% sensitivity and 76% specificity (AUC 0.846). Conclusions: EDSPA is a useful, non-invasive, and reproducible echocardiographic measure of PAMP that is easy to perform. With a sensitivity and specificity near 80%, it has significant utility in screening for pulmonary hypertension and determining which patients should undergo further invasive diagnostic testing.


2016 ◽  
Vol 30 (1) ◽  
pp. 27-28 ◽  
Author(s):  
Md Serajul Haque ◽  
HI Lutfur Rahman Khan ◽  
Razia Sultana Mahmud ◽  
Md Faruq ◽  
Abdul Wadud Chowdury ◽  
...  

The objective of this study was to see the incidence of pulmonary hypertension and its age distribution in atrial septal defect (ASD) patients in our population. A total of 58 ASD (secundum type) patients were included in the study. The diagnosis was done with echocardiography. Subsequently patients under went cardiac catheterization and their pulmonary artery (PA) mean pressure was measured. It was seen that pulmonary pressure increases with age. Severe PA hypertension (mean pressure > 40 mm Hg) was found in 14 patients (24.14%), age range was 10-55 years but most of them were more than 20 years old.Bangladesh Heart Journal 2015; 30(1) : 27-28


Sign in / Sign up

Export Citation Format

Share Document